Lv6
1926 积分 2024-10-03 加入
A modular framework for antibody–drug conjugate biomarkers
11天前
已完结
Development of a novel Fc fusion protein dual glucagon-like peptide-1 and gastric inhibitory polypeptide receptor agonists
1个月前
已完结
Antibody–Drug Conjugates in SCLC: DLL3, B7-H3, TROP2, and Beyond
1个月前
已完结
Targeting claudins in cancer
1个月前
已完结
Realizing the potential of agonistic antibody immunotherapy
1个月前
已完结
China’s drug discovery strategy: established targets, combination approaches, and small-molecule optimization
1个月前
已完结
From biologics to small-molecule modulators: the evolving landscape of interleukin-targeted therapeutics
2个月前
已完结
Recent advances in function-enhanced antibody-drug conjugates: Antibody optimization and payload combination
2个月前
已完结
AI-driven discovery of GPNMB CAR T cells as a multi-cancer therapy
3个月前
已完结
Bispecific antibody–drug conjugates: a modular blueprint for next-generation cancer therapeutics
4个月前
已完结
皖公网安备34019202002308
